Formula Growth’s LeMaitre Vascular LMAT Stock Holding History

Formula Growth’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-18,000	Closed	-$586K	–	152
2020 Q3	$586K	Hold	18,000	–	–	0.11%	140
2020 Q2	$475K	Hold	18,000	–	–	0.08%	136
2020 Q1	$449K	Sell	18,000 -15,000	-45%	-$463K	0.09%	125
2019 Q4	$1.19M	Hold	33,000	–	–	0.15%	110
2019 Q3	$1.13M	Sell	33,000 -5,000	-13%	-$160K	0.17%	112
2019 Q2	$1.06M	Hold	38,000	–	–	0.15%	120
2019 Q1	$1.18M	Hold	38,000	–	–	0.17%	108
2018 Q4	$898K	Hold	38,000	–	–	0.15%	114
2018 Q3	$1.47M	Hold	38,000	–	–	0.17%	109
2018 Q2	$1.27M	Hold	38,000	–	–	0.14%	118
2018 Q1	$1.38M	Hold	38,000	–	–	0.16%	115
2017 Q4	$1.21M	Hold	38,000	–	–	0.16%	108
2017 Q3	$1.42M	Sell	38,000 -10,000	-21%	-$340K	0.22%	104
2017 Q2	$1.5M	Sell	48,000 -10,000	-17%	-$289K	0.26%	98
2017 Q1	$1.43M	Buy	+58,000	New	+$1.36M	0.3%	97

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCA

Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Formula Growth's LMAT Position: Q4 2020 in Review

Formula Growth sold out of LeMaitre Vascular (LMAT) in Q4 2020, closing a stake of 18,000 shares — an estimated $586K sold.

Formula Growth first reported a position in LMAT in Q1 2017 and held it in 15 quarters. The position peaked at $1.5M in Q2 2017. 179 funds tracked by Wall St. Rank hold LMAT as of Q4 2020.

Formula Growth reported no remaining LeMaitre Vascular position as of Q4 2020 after selling out during the quarter.
Formula Growth sold 18,000 LeMaitre Vascular shares in Q4 2020, an estimated $586K.
Formula Growth first reported a position in LeMaitre Vascular in Q1 2017 and held it in 15 quarters.
Formula Growth's LeMaitre Vascular position peaked at $1.5M in Q2 2017.
179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2020.

Based on Formula Growth's 13F filing for Q4 2020, filed 12 Feb 2021.